ALLO Competitors & Alternatives
Compare Allogene Therapeutics Inc with similar stocks in the same industry
Biotechnology
ALLO
Main Stock$1.78
Tradestie Score
46
Market Cap
$275.13M
Revenue Growth
-1.0%
Analyst Upside
+405.6%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 49 | Compare |
|
ARVN
Arvinas, Inc
|
$8.45
|
$670.30M | 33.5 | 33 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$12.79
|
$665.30M | 14.8 | 41 | Compare |
|
MPLT
MPLT
|
$13.00
|
$639.32M | - | 31 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$15.88
|
$626.91M | - | 57 | Compare |
|
SVRA
Savara Inc.
|
$5.30
|
$611.84M | - | 50 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.29
|
$552.46M | - | 48 | Compare |
|
VSTM
Verastem, Inc.
|
$7.32
|
$541.60M | - | 46 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$12.91
|
$540.97M | - | 48 | Compare |
More ALLO Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2836)
235 stocks in this industry